期刊文献+

COPD患者血清中8-异前列腺素的检测及其意义 被引量:1

Clinic significances of 8-isoprostane in serum in COPD
暂未订购
导出
摘要 目的研究慢性阻塞性肺疾病(COPD)患者血清中8-异前列腺素(8-isoPG)浓度的改变及临床意义。方法收集COPD患者(40例)急性发作期和缓解期以及正常对照组(30例)的血清,用酶标记法检测血清中8-isoPG,同时检测AECOPD患者的第一秒呼气容量(FEV1)、最大呼气流速(PEF)、pH值、PaCO2、PaO2及血白细胞总数。结果①COPD患者急性发作期8-isoPG为35.43±7.29ng/L,高于缓解期(24.71±8.25ng/L)及正常对照组(13.31±6.19ng/L),P<0.05;②COPD患者8-isoPG浓度与痰量呈正相关,r=0.217,P<0.05。结论 COPD的急性发作期,8-isoPG升高反映了氧化应激增强。 Objective To study the changes and clinic significances of 8-isoprostane (8-isoPG)in serum in patients of chronic obstructive pulmonary disease(COPD).Methods Serum of 39 cases in acute episode COPD(AECOPD) and period of remission ,and that of 32 normal person were collected. EIA enzyme labeling regulation was used for assaying the density of 8-isoPG in serum. Forced expiratory volume in one second (FEV1) and peak expiratory flow(PEF) of AECOPD patients were observed at the same time, and pH, PaCO2, PaO2, SaO2, leukocyte were assayed also.Results ① The concentration of 8-isoPG in serum in AECOPD was 35.43±7.29 ng/L, and that was 24.71±8.25 ng/L in remission of COPD and that was 13.31±6.19 ng/L in normal controls,P0.05. ② The concentration of 8-isoPG in serum had positive relationship with the volume of sputum in AECOPD patients,r=0.217,P0.05.Conclusions The concentration of 8-isoPG in serum in AECOPD patients were raised when oxidation stress was reinforced.
出处 《临床肺科杂志》 2010年第11期1605-1606,共2页 Journal of Clinical Pulmonary Medicine
关键词 呼出气冷凝液 慢性阻塞性肺病 8-异前列腺素 serum chronic obstructive pulmonary disease 8-isoprostane
  • 相关文献

参考文献8

  • 1李靖,郑劲平,袁锦屏,杨灵,罗锭芬,安嘉颍,肖正伦,钟南山,钟维农,何为国,赵子文,曾军,林材元.口服八种细菌提取物对慢性支气管炎合并慢性阻塞性肺疾病急性加重的预防作用[J].中华结核和呼吸杂志,2004,27(9):631-633. 被引量:30
  • 2Pauwels R.Global initiative for chronic obstructive lung diseases (GOLD):time to act[J].Eur Respir J,2001,18(6):901-902.
  • 3Risby TH.Further discussion on breath condensate analysis[J].Am J Respir Crit Care Med,2003,167(10):1301-1302.
  • 4Fong CY,Pang L,Holand E,et al.TGF-beta1 stimulates IL-8 release,COX-2 expression,and PGE(2),release in human airway smooth muscle cells[J].Am J Physiol Lung Cell Mol Physiol,2000,279(1):201-207.
  • 5Taha R,Olivenstein R,Utsumi T,et al.Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2000,161(2 pt 1):636-640.
  • 6Schwedhelm E,Tsikas D,Durand T,et al.Tandem mass spectrometric quantification of 8-isoproistaglandin F2alpha and its metabolite 2,3-dinor-56-dihydro-8-isoprostaglanin F2alpha in human urine[J].J Chromatogr B Biomed Sci Appl,2000,744(1):99-112.
  • 7Schulz C,WoIf K,Harth M,et al.Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease,smokers,and never-smokers[J].Respiration,2003,70(5):254-261.
  • 8Pauwels A,Buist A,Calverley P,et al.Global Strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease.NHLBI/WHO Global initiative for chronic obstructive lung disease(GOLD) Workshop Summary[J].Am J Respir Crit Care Med,2001,163(5):1256-1276.

二级参考文献7

  • 1Pennington JE,Miler JJ. Evaluation of a new polyvalent Pseudomonas vaccine in respiratory infections. Infect Immun,1979,5:1029-1034.
  • 2Mauel J,van Pham T,Kreis B,et al. Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages. Int J Immunopharmacol,1989,11:637-645.
  • 3Cvoriscec B,Ustar M,Pardon R,et al. Oral immunotherapy of chronic bronchitis:a double-blind placebo-controlled multicentre study. Respiration,1989,55:129-135.
  • 4Gutierrez-Tarango MD,Berber A. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. Chest,2001,119:1742-1748.
  • 5Orcel B,Delclaux B,Baud M,et al. Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. Eur Respir J,1994,7:446-452.
  • 6Emmerich B,Emslander HP,Pachmann K,et al. Local immunity in patients with chronic bronchitis and the effects of a bacterial extract,Broncho-Vaxom,on T lymphocytes,gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other va
  • 7赵鸣武,顾国忠,刘振英,张小伟,许伟,方秋红.慢性阻塞性肺疾病患者细菌感染的临床观察[J].中华结核和呼吸杂志,1999,22(2):88-91. 被引量:32

共引文献29

同被引文献9

  • 1Weldon S, McGarry N, Taggart CC, et al. The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses [ J]. Biochem Soc Trans, 2007 Apt ;35 ( Pt 2) :273 - 6.
  • 2Kersul AL, Iglesias A, Rlos A, et al. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease [ J 1. Arch Bronconeumol, 2011 Apr ;47 (4) : 176 - 83.
  • 3Parameswaran GI, Sethi S, Murphy TF, et al. Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD [J]. Chest, 2011 Sep;140(3) :611 -7.
  • 4Pant S, Waiters EH, Griffiths A, et ai. Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD [ J ]. Respirology, 2009 May ; 14 (4) :495 - 503.
  • 5Tateosian NL, Costa M J, Guerrieri D, et al. Inflammatory media- tors in exhaled breath condensate of healthy donors and exacerbated COPD patients[ J ]. Cytokine, 2012 Jun ;58 (3) :361 - 7.
  • 6Hollander C, Sitkauskiene B, Sakalauskas R, Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and slCAM-1 in patients with COPD and asthma [ J ]. Respir Med, 2007 Sep; 101 (9) :1947 -53.
  • 7Wex T, Sokic-Milutinovic A, Todomvic V, et al. Down-regulation of secretory leukocyte protease inhibitor expression in gastric mucosa is a general phenomenon in Helicobacter pylofi-related gastroduodenal diseases[ J]. Dig Dis,2004,22:390 - 395.
  • 8陈金亮,陈建荣,蔡映云,陶一江,陶国华,张扬.COPD患者呼出气冷凝液中8-异前列腺素的检测及其意义[J].临床肺科杂志,2011,16(3):341-343. 被引量:17
  • 9陈济明,周燕宁,刘红光,李一禄,徐健.COPD无创通气患者呼出气冷凝液亚硝酸盐/硝酸盐检测意义[J].临床肺科杂志,2013,18(9):1553-1555. 被引量:5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部